表1.
225例肺腺癌患者临床特征的单因素分析
| Variables | Total (n=225) | VTE | P | |
|---|---|---|---|---|
| Negative (n=193) | Positive (n=32) | |||
| Gender | 0.76 | |||
| Female | 97 (43.11%) | 84 (43.52%) | 13 (40.62%) | |
| Male | 128 (56.89%) | 109 (56.48%) | 19 (59.38%) | |
| Age (yr) | 0.58 | |||
| Mean±SD | 59.65±9.07 | 59.51±9.16 | 60.47±8.59 | |
| BMI (kg/m2) | 0.75 | |||
| Mean±SD | 23.84±3.24 | 23.81±3.19 | 24.01±3.58 | |
| Smoking history | 0.54 | |||
| Without | 158 (70.22%) | 137 (70.98%) | 21 (65.63%) | |
| With | 67 (29.78%) | 56 (29.02%) | 11 (34.37%) | |
| Alcohol abuse | 0.10 | |||
| Without | 196 (87.11%) | 171 (88.60%) | 25 (78.13%) | |
| With | 29 (12.89%) | 22 (11.40%) | 7 (21.87%) | |
| Hypertension | 0.09 | |||
| Without | 162 (72.00%) | 143 (74.09%) | 19 (59.38%) | |
| With | 63 (28.00%) | 50 (25.91%) | 13 (40.62%) | |
| Diabetes | 0.35 | |||
| Without | 200 (88.89%) | 170 (88.08%) | 30 (93.75%) | |
| With | 25 (11.11%) | 23 (11.92%) | 2 (6.25%) | |
| Cardiovascular diseases | 0.62 | |||
| Without | 214 (95.11%) | 183 (94.82%) | 31 (96.88%) | |
| With | 11 (4.89%) | 10 (5.18%) | 1 (3.12%) | |
| Cerebrovascular diseases | 0.34 | |||
| Without | 209 (92.89%) | 178 (92.23%) | 31 (96.88%) | |
| With | 16 (7.11%) | 15 (7.77%) | 1 (3.12%) | |
| Pulmonary diseases | 0.20 | |||
| Without | 214 (95.11%) | 185 (95.85%) | 29 (90.62%) | |
| With | 11 (4.89%) | 8 (4.15%) | 3 (9.38%) | |
| Hepatic disease | 0.37 | |||
| Without | 217 (96.44%) | 187 (96.89%) | 30 (93.75%) | |
| With | 8 (3.56%) | 6 (3.11%) | 2 (6.25%) | |
| Kidney disease | 0.68 | |||
| Without | 224 (99.56%) | 192 (99.48%) | 32 (100.00%) | |
| With | 1 (0.44%) | 1 (0.52%) | 0 (0.00%) | |
| Thyroid diseases | 0.56 | |||
| Without | 223 (99.11%) | 191 (98.96%) | 32 (100.00%) | |
| With | 2 (0.89%) | 2 (1.04%) | 0 (0.00%) | |
| aCCI (points) | 0.89 | |||
| Median (Q1, Q3) | 2 (1, 3) | 2 (1, 3) | 2 (1, 2) | |
| VTE history | <0.05 | |||
| Without | 222 (98.67%) | 193 (100.00%) | 29 (90.63%) | |
| With | 3 (1.33%) | 0 (0.00%) | 3 (9.37%) | |
| Follow-up period (d) | 0.49 | |||
| Median (Q1, Q3) | 125.3 (84, 189) | 126 (105, 210) | 123 (42, 194) | |
VTE: venous thromboembolism; BMI: body mass index; aCCI: age-adjusted Charlson comorbidity index.